Journals / Laparoscopic Endoscopic Surgical Science / 2019 / Cilt: 26 - Sayı: 2

Evaluation of the results of colonoscopy in patients with a positive fecal occult blood test for colorectal cancer

Pages
37–40
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Nonneoplastic polyps were detected in 41 patients.Conclusion: The use of a fecal occult blood test in colorectal cancer screening followed by a colonoscopy when there are positive test results is an effective and essential method of assessment

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The objective of this study was to present the pathological fidings of fecal occult blood tests and results of colonoscopy procedures to discuss the clinical implications in the context of the current literature.Materials and Methods: The results of a total of 205 patients (122 male, 83 female) aged 50 to 75 years who underwent a fecal occult blood test for stitching without a clinical complaint and who underwent colonoscopy due to positive results were retrospectively reviewed.
📊
Key Findings & Data:Fecal occult blood screening was performed using the fecal immunochemical test method in all patients.Results: The mean age of the patients was 63 years (range: 50–75 years).
💡
Conclusion & Impact:Nonneoplastic polyps were detected in 41 patients.Conclusion: The use of a fecal occult blood test in colorectal cancer screening followed by a colonoscopy when there are positive test results is an effective and essential method of assessment
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Introduction: The objective of this study was to present the pathological fidings of fecal occult blood tests and results of colonoscopy procedures to discuss the clinical implications in the context of the current literature.Materials and Methods: The results of a total of 205 patients (122 male, 83 female) aged 50 to 75 years who underwent a fecal occult blood test for stitching without a clinical complaint and who underwent colonoscopy due to positive results were retrospectively reviewed. Fecal occult blood screening was performed using the fecal immunochemical test method in all patients.Results: The mean age of the patients was 63 years (range: 50–75 years). Of these patients, 13 (63%) were found to have a colon tumor, 59 (28.7%) had colon polyps, 1 (53%) had colon diverticulum, 8 (3.9%) had inflammatory bowel cast, 6 (2.8%) had hemorrhoids, and anal fisure was determined in 3 (1.4%). Nine (69%) of those with colorectal cancer were in the early stages (stage I–II), 2 patients (15%) were in the advanced stage and 2 patients (15%) were in the advanced stage. Non-neoplastic polyps were found in 18 of the 59patients with colon polyps. Nonneoplastic polyps were detected in 41 patients.Conclusion: The use of a fecal occult blood test in colorectal cancer screening followed by a colonoscopy when there are positive test results is an effective and essential method of assessment

🔖

Cite This Article

KOCA, B. (2019). Evaluation of the results of colonoscopy in patients with a positive fecal occult blood test for colorectal cancer. Laparoscopic Endoscopic Surgical Science, Cilt: 26 - Sayı: 2, 37–40. https://ajindex.com/articles/345102

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Song LL, Li YM. Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests. World J Gastrointest Oncol 2016;8:793–800
  2. Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP, et al. Colorectal cancer screening: a global overview of existing programmes. Gut 2015;64:1637–49
  3. Högberg C, Samuelsson E, Lilja M, Fhärm E. Could it be colorectal cancer? General practitioners’ use of the faecal occult blood test and decision making-a qualitative study. BMC Fam Pract 2015;16:153
  4. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374–403
  5. Lansdorp-Vogelaar I, von Karsa L; International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition-Introduction. Endoscopy 2012;44:SE15–30
  6. Bampton PA, Sandford JJ, Cole SR, Smith A, Morcom J, Cadd B, et al. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology. Gut 2005;54:803–6
  7. Finkelstein S, Bini EJ. Annual Fecal Occult Blood Testing Can Be Safely Suspended for Up To 5 Years After a Negative Colonoscopy in Asymptomatic Average-Risk Patients. Gastrointest Endosc 2005;61:AB250
  8. Areia M, Fuccio L, Hassan C, Dekker E, Dias-Pereira A, Dinis-Ribeiro M. Cost-utility analysis of colonoscopy or faecal immunochemical test for population-based organised colorectal cancer screening. United European Gastroenterol J 2019;7:105–13
  9. Allison JE, Fraser CG, Halloran SP, Young GP. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver 2014;8:117–30
  10. Narula N, Ulic D, Al-Dabbagh R, Ibrahim A, Mansour M, Balion C, et al. Fecal occult blood testing as a diagnostic test in symptomatic patients is not useful: a retrospective chart review. Can J Gastroenterol Hepatol 2014;28:421–6
  11. Fu Y, Wang L, Xie C, Zou K, Tu L, Yan W, et al. Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation. Sci Rep 2017;7:2669
  12. Dalle I, Geboes K. Vascular lesions of the gastrointestinal tract. Acta Gastroenterol Belg 2002;65:213–9
  13. Papaconstantinou HT, Thomas JS. Bacterial c